Julie Donaghey

Principal Scientist at TCR2 Therapeutics - Cambridge, MA, US

Julie Donaghey's Contact Details
HQ
617-949-5200
Location
Boston, Massachusetts
Company
TCR2 Therapeutics
Julie Donaghey's Company Details
TCR2 Therapeutics logo, TCR2 Therapeutics contact details

TCR2 Therapeutics

Cambridge, MA, US • 250 - 499 Employees
BioTech/Drugs

TCR² Therapeutics Inc. is a clinical-stage cell therapy company developing a pipeline of novel T cell therapies for patients suffering from solid tumors. The company is focused on the discovery and development of product candidates against novel and complex targets utilizing its proprietary T cell receptor (TCR) Fusion Construct T cells (TRuC®-T cells). The TRuC platform is designed to specifically recognize and kill cancer cells by harnessing signaling from the entire TCR, independent of human leukocyte antigens (HLA). For more information about TCR², please visit www.tcr2.com.

Cancer therapy T cell biology Immunology Molecular biology Biotech Biotech
Details about TCR2 Therapeutics
Frequently Asked Questions about Julie Donaghey
Julie Donaghey currently works for TCR2 Therapeutics.
Julie Donaghey's role at TCR2 Therapeutics is Principal Scientist.
Julie Donaghey's email address is ***@tcr2.com. To view Julie Donaghey's full email address, please signup to ConnectPlex.
Julie Donaghey works in the BioTech/Drugs industry.
Julie Donaghey's colleagues at TCR2 Therapeutics are Ella Liberzon, Amy Watt, Ryan Milione, Courtney Anderson, Munisha Smalley, Fiona Modricker, Jian Ding and others.
Julie Donaghey's phone number is 617-949-5200
See more information about Julie Donaghey